This inquiry requires careful consideration due to the numerous psychiatric medications that list “SUICIDE” among their contraindications. This exploration is essential, given the uninformed consumption of these products by the public, who often remain oblivious to the associated risks.
The immediate answer could be YES; various psychiatric medications may, in certain cases, heighten the risk of suicidal thoughts or behaviors, particularly at the onset of treatments and during dosage adjustments. Often, when such medications are prescribed by general practitioners, the issue is not thoroughly analyzed, and despite discussions around monitoring, many do not receive such oversight. Would psychiatrists perform better? I have my reservations.
To be fair, this does not mean medications directly cause suicide, but they do affect factors that temporarily raise the risk, a concern that is insufficiently addressed.
Antidepressants, specifically selective serotonin reuptake inhibitors like fluoxetine, sertraline, and paroxetine, can induce symptoms requiring urgent monitoring in the initial weeks, including heightened anxiety, agitation, insomnia, and increased energy, preceding any perceived improvement in depression. This creates a scenario where one might be driven to act yet lack the energy to do so, leading to frustration and helplessness. Organizations like the FDA and EMA have been cautioning for years about the increased risk of suicidal thoughts in adolescents and young adults, particularly at the start of treatment.
Mood stabilizers and antipsychotics also present negative contraindications, with potential severe side effects like anxiety and akathisia. Akathisia, characterized by restlessness and inability to remain still, can necessitate additional treatment due to its mental impact. This cycle of treatment can become destabilizing if not managed carefully, leading to a permanent state of imbalance and labeling as MENTALLY ILL, whereby one’s opinions may no longer be valued: “What could you know if you are mentally ill?”
Experts emphasize the need for precise initial diagnoses to tailor appropriate medication types and doses. Following this, ongoing medical supervision is crucial during the crucial first week. However, given the strain on medical services, this only complicates matters for patients, who may face social stigmatization as “mentally ill,” further affecting their emotional state and potentially fostering delusional or suicidal ideation.
In light of this, I advocate for the right not to be labeled as mentally ill and to curb the authority of doctors and psychiatrists from using such labels to prescribe medication at their discretion.
Leave a Reply